Born in Bologna (Italy) the 28th of May, 1966, Graduated in Medicine and Surgery with honours at the University of Bologna in 1991, Specialization with honours in Pathology and Cytology at the University of Parma in 1996, Employed as a pathologist at the General Hospital G.B.Morgagni-L.Pierantoni of Forlì (Italy) since1993, Pathologist Referent for Regional Program of Screening of cervical, breast and colon cancer, Responsible of the Laboratory of Oncologic and Clinic Cytology in the Department of Pathology since 2002, Co-author of the Manuscript : “Diagnostic and therapeutic protocols in Thyroid Pathology”, considered as guide lines in our Hospital, Speaker in more than 100 National and International Congresses and Scientific Meetings, More than 120 National and International Congresses attended More than 50 Abstract presented at National and International Congresses,- More than 70 Events of Screening of cervical, colon and breast cancer attended, Member founder of International Gastric Cancer Association, founded at Kyoto (Japan) in 1995, Member founder of the Italian Research Group of Gastric Cancer, founded in 2001, Teacher in Specialistic Courses of Immunohistochemistry, held for pathologists, biologists and technicians,
He had graduated medical school at Diyarbakir University. Professor Vedat Goral is currently working at the Department of Gastroenterology, at Istanbul Medipol University School of Medicine. Previous to this, he was working at the Dicle University from 1987 to 2012 and Izmir Medicalpark Hospital from 2012 till 2017. His specific teaching and research interests are in the areas of Gastroenterology (endoscopy, gastrointestinal diseases, liver diseases, inflammatory bowel diseases and ERCP). He has also published many refereed articles in journals covered by SCI, and contributed some to Turkish books written in Turkish. Also, he has many abstracts at national and international congress.
The genetics and epigenetic basis of gastrointestinal cancers, Familial cancers and polyposis syndromes, Cancer epigenetics, including the role of DNA methylation, Non‐coding RNA and microRNAs and their role in cancer pathogenesis, Molecular pathology and diagnostics for gastrointestinal cancers, Prognostic and predictive biomarkers for colorectal cancer, Cancer disparities among different racial/ethnic populations, Personalized medicine for gastrointestinal cancers, Chemoprevention, using complementary and alternative approaches.
Research Interest: Surgical treatment of colorectal cancer (open and
laparoscopic), Surgical treatment of IBD, MIS-laparoscopic abdominal surgery,
Multimodal treatment of gastric cancer, Main research interest is the field of Surgical
management in gastrointestinal oncology.
Research Interest:Gastrointestinal Oncology;
Upper Gastrointestinal Tract Disorders; Multimodal Treatment; Stomach Cancer;
Espohageal Cancer and Surgery.
Research Interest:Oncology, International
Society of Pediatric Oncology, European Hematology Association, Histiocyte
Society and European Society of Paediatric Haematology and Immunology.
Research Interest: The fields of his principal scientific
investigations are focused on pathogenesis and clinical manifestations of
psoriasis, comorbidities and biotechnological treatments - infectious diseases,
with particular emphasis on parasitic infestations and venereal diseases -
Cutaneous adverse drug reactions and pharmacovigilance - Diagnosis.
Research Interest: Colorectal Cancer, Laparoscopic surgery,
Diverticular Disease, Emergency operations, Health services research, Basic
science research and anal fistula.
Research Interest:Medicinal plants in the
pathophysiology of the diseases that affect the gastrointestinal tract (peptic
ulcers and inflammatory bowel disease).
Research Interest: Pharmacotherapeutics of chronic liver diseases; Early
diagnosis and treatment of gastrointestinal tumors; Evidence-based medical
research of digestive diseases; Effects of autophagy in liver diseases and
other digestive tumors.
Research Interest: Colorectal diseases, colorectal surgery,
endoscopy, minimally invasive surgery, surgical oncology, trauma and emergency
surgery, thyroid disease, perianal disease, hernia, breast disease,health care
management, clinical and experimental research, database management, fund
raising, surgical education, medical education and ethics.
Each step from submission to publication was handled efficiently. The review comments were accurate which increased the value of our revised manuscript. I will certainly publish more works with Peertechz.More
C
cantrella caralynn
It was found that each step in the submission and publishing process was handled efficiently. The reviewers were clearly experts in the field and our revised manuscript was dealt with value.More
S
Samantha Wyatt
The entire review and production process for the article has been handled with remarkable professionalism and efficiency. As the editor, I can appreciate the enormous organizational effort and discipline shown.More
MUSHTAQ CHALKOO
Tomorrow is a search of today and if we research,we add an another day,that is how the time pulls on and on.Science keeps on changing its facies and thus paradigm and makes our living interesting and awesome.The knowledge of science needs to be dissipated to the progeny for better living ahead and the way we do that is through scientific journals published by different publication houses.Being associated with peertechz publications has been a wonderful experience.i have enjoyed the true spirit of scientific spice serving the organisation as an editor.It is author friendly,and makes the publication process for you very easy taking care not to jeopardise the standards of true science.I would suggest the research scholars and young scientists to associate with this publication house ,submit your reseach to brighten your career ahead in science.let us keep up the spirit of spreading the true science to the world ahead.More
Dr Shivaji Jadhav
Wonderful ..process and indeed very good way in terms of communication and i recommend for publishing with this publishers...Great support.More